Para pesquisar informação científica, deverá especificar pelo menos dois termos de pesquisa
Search Medical Information
October 16 – 19 , 2024
PDF
A Need for Infection Prevention Among Patients With ESKD on Maintenance Dialysis: A First Step in Understanding How SARS-CoV-2 Impacts This Population
Individuals on Immunosuppressive or Immunomodulatory Therapies Remain at Increased Risk of COVID-19 Hospitalization, Despite Vaccination: Findings from INFORM, a Retrospective Health Database Study in England
COVID-19 Mortality Among Immunocompromised Individuals Is Consistently High Compared With Non-Immunocompromised Individuals: Results of the INFORM Study 2022, England
Safety and Pharmacokinetics of Long-acting SARS-Cov-2 Antibodies Tixagevimab/Cilgavimab (AZD7442) are Consistent After Repeat Dosing: Results From the PROVENT Substudy
Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants
Safety and Immunogenicity of a Respiratory Syncytial Virus and Human Metapneumovirus Virus-Like Particle Protein Subunit Combination Vaccine in 60 to 85-Year-Old Adults: Interim Results from a Phase 2a Clinical Trial
Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children: Data From the 2023/24 Influenza Season
Clinical Outcomes in Adults Hospitalized with Viral Lower Respiratory Tract Disease with a Bacterial and/or Fungal Coinfection: A US Claims Data Base Study
Temporal Patterns of Hospitalizations and Clinical Outcomes Associated with Viral Lower Respiratory Tract Disease in 2015-2023: A US Claims Analysis
Não encontra o que procura?
Contacte-nos
Encontre um Medical Healthcare Partner
Submeter uma questão